CHEMOTHERAPY: Bill One E/M Service Before 78804 And 79403

Why This Topic Matters

The piece helps readers distinguish among related nuclear medicine and oncology billing components, understand when a separate evaluation and management service may be considered, and recognize that some administration services may be included in the overall procedure. It also highlights how coding language changes can affect reporting practices.

Article Sections

1. Carrier guidance on radiopharmaceutical localization testing

   Summarizes payer guidance on billing for newer radiopharmaceutical localization studies and the general workflow described for those services. It also covers documentation and physician oversight themes.

2. Reporting diagnostic and therapeutic services separately

   Discusses how diagnostic and therapeutic components are handled on claims and addresses related evaluation and management reporting at a broad level. The section also notes the treatment of associated administration services within the overall procedure.

3. 2004 CPT update context

   Reviews a coding update described in the article and places it in the context of changing radiopharmaceutical practice. The discussion is limited to the general nature of the descriptor revisions.